Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease

doi:10.17816/KMJ7832

Kazan medical journal ›› 2018, Vol. 99 ›› Issue (1) DOI: 10.17816/KMJ7832

Cochrane Review Summaries

other

Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease

Author information +

History +

PDF

Abstract

Cite this article

Download citation ▾

. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Kazan medical journal, 2018, 99(1): DOI:10.17816/KMJ7832